Status:

UNKNOWN

Biomarkers of Acute Kidney Injury in Cardiac Surgery

Lead Sponsor:

Nikola Bradic, MD

Conditions:

Acute Kidney Injury (Nontraumatic)

Eligibility:

All Genders

18-80 years

Brief Summary

Acute kidney injury (AKI) is the most common complication in patients after cardiac surgery. An usual estimation of risk for AKI is estimation of serum creatinine, which is unreliable indicator of AKI...

Eligibility Criteria

Inclusion

  • patients scheduled for cardiac surgery (CABG, valve replacement/repair, combined)
  • older than 18 years

Exclusion

  • previous known renal disease
  • patients on chronic dialysis

Key Trial Info

Start Date :

December 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03830450

Start Date

December 1 2020

End Date

December 31 2022

Last Update

November 13 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Biomarkers of Acute Kidney Injury in Cardiac Surgery | DecenTrialz